 |
Previous Article | Next Article 
The Journal of Neuroscience, April 15, 1998, 18(8):3035-3042
Adrenergic 2C-Receptors Modulate the Acoustic
Startle Reflex, Prepulse Inhibition, and Aggression in Mice
Jukka
Sallinen1,
Antti
Haapalinna2,
Timo
Viitamaa2,
Brian K.
Kobilka3, and
Mika
Scheinin1
1 Department of Pharmacology and Clinical Pharmacology,
University of Turku, FIN-20520 Turku, Finland, 2 Orion
Corporation, Orion Pharma, FIN-20101 Turku, Finland, and
3 Department of Molecular and Cellular Physiology, Howard
Hughes Medical Institute, and Division of Cardiovascular Medicine,
Stanford University, Stanford, California 94305
Studies on animal models of stress, anxiety, aggression, and
sensorimotor gating have linked specific monoamine neurotransmitter abnormalities to the cognitive and behavioral disturbances associated with many affective neuropsychiatric disorders. Although
2-adrenoceptors ( 2-ARs) have been
suggested to have a modulatory role in these disorders, the specific
roles of each 2-AR subtype ( 2A,
2B, and 2C) are largely
unknown. The restricted availability of relevant animal models and the
lack of subtype-selective 2-AR drugs have precluded
detailed studies in this area. Therefore, transgenic mice were used to
study the possible role of the 2C-AR subtype in two well
established behavioral paradigms: prepulse inhibition (PPI) of the
startle reflex and isolation-induced aggression. The
2C-AR-altered mice appear grossly normal, but subtle
changes have been observed in their brain dopamine (DA) and serotonin (5-HT) metabolism. In this study, the mice with targeted inactivation of the gene encoding 2C-ARs ( 2C-KO) had
enhanced startle responses, diminished PPI, and shortened attack
latency in the isolation-aggression test, whereas tissue-specific
overexpression of 2C-ARs ( 2C-OE) was
associated with opposite effects. Correlation analyses suggested that
both the magnitude of the startle response and its relative PPI (PPI%)
were modulated by the mutations. In addition, the differences in PPI,
observed between drug-naive 2C-OE mice and their
wild-type controls, were abolished by treatment with a subtype
nonselective 2-agonist and antagonist. Thus, drugs
acting via 2C-ARs might have therapeutic value in
disorders associated with enhanced startle responses and sensorimotor
gating deficits, such as schizophrenia, attention deficit disorder,
post-traumatic stress disorder, and drug withdrawal.
Key words:
2C-adrenoceptor; gene-targeting; isolation-induced aggression; schizophrenia; sensorimotor gating; startle; transgenic mice
Copyright © 1998 Society for Neuroscience 0270-6474/98/1883035-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Solis and D. J. Perkel
Noradrenergic Modulation of Activity in a Vocal Control Nucleus In Vitro
J Neurophysiol,
April 1, 2006;
95(4):
2265 - 2276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Stein, W. Bergman, Y. Fang, L. Davison, C. Brensinger, M. B. Robinson, N. B. Hecht, and T. Abel
Behavioral and neurochemical alterations in mice lacking the RNA-binding protein translin.
J. Neurosci.,
February 22, 2006;
26(8):
2184 - 2196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. F. Schwindinger, K. S. Betz, K. E. Giger, A. Sabol, S. K. Bronson, and J. D. Robishaw
Loss of G Protein gamma 7 Alters Behavior and Reduces Striatal alpha olf Level and cAMP Production
J. Biol. Chem.,
February 14, 2003;
278(8):
6575 - 6579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Philipp, M. Brede, and L. Hein
Physiological significance of alpha 2-adrenergic receptor subtype diversity: one receptor is not enough
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2002;
283(2):
R287 - R295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Fairbanks, L. S. Stone, K. F. Kitto, H. O. Nguyen, I. J. Posthumus, and G. L. Wilcox
alpha 2C-Adrenergic Receptors Mediate Spinal Analgesia and Adrenergic-Opioid Synergy
J. Pharmacol. Exp. Ther.,
January 1, 2002;
300(1):
282 - 290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Viramontes, A. Malcolm, M. Camilleri, L. A. Szarka, S. McKinzie, D. D. Burton, and A. R. Zinsmeister
Effects of an alpha 2-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans
Am J Physiol Gastrointest Liver Physiol,
December 1, 2001;
281(6):
G1468 - G1476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Millan, F. Lejeune, A. Gobert, M. Brocco, A. Auclair, C. Bosc, J.-M. Rivet, J.-M. Lacoste, A. Cordi, and A. Dekeyne
S18616, a Highly Potent Spiroimidazoline Agonist at alpha 2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
J. Pharmacol. Exp. Ther.,
December 1, 2000;
295(3):
1206 - 1222.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. W. Kable, L. C. Murrin, and D. B. Bylund
In Vivo Gene Modification Elucidates Subtype-Specific Functions of alpha 2-Adrenergic Receptors
J. Pharmacol. Exp. Ther.,
April 1, 2000;
293(1):
1 - 7.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Olli-Lahdesmaki, J. Kallio, and M. Scheinin
Receptor Subtype-Induced Targeting and Subtype-Specific Internalization of Human alpha 2-Adrenoceptors in PC12 Cells
J. Neurosci.,
November 1, 1999;
19(21):
9281 - 9288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Altman, A. U. Trendelenburg, L. MacMillan, D. Bernstein, L. Limbird, K. Starke, B. K. Kobilka, and L. Hein
Abnormal Regulation of the Sympathetic Nervous System in alpha 2A-Adrenergic Receptor Knockout Mice
Mol. Pharmacol.,
July 1, 1999;
56(1):
154 - 161.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Zhang, V. Klimek, J. T. Farley, M.-Y. Zhu, and G. A. Ordway
alpha 2C Adrenoceptors Inhibit Adenylyl Cyclase in Mouse Striatum: Potential Activation by Dopamine
J. Pharmacol. Exp. Ther.,
June 1, 1999;
289(3):
1286 - 1292.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. M. Small, S. L. Forbes, F. F. Rahman, K. M. Bridges, and S. B. Liggett
A Four Amino Acid Deletion Polymorphism in the Third Intracellular Loop of the Human alpha 2C-Adrenergic Receptor Confers Impaired Coupling to Multiple Effectors
J. Biol. Chem.,
July 21, 2000;
275(30):
23059 - 23064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Hurt, F. Y. Feng, and B. Kobilka
Cell-type Specific Targeting of the alpha 2c-Adrenoceptor. EVIDENCE FOR THE ORGANIZATION OF RECEPTOR MICRODOMAINS DURING NEURONAL DIFFERENTIATION OF PC12 CELLS
J. Biol. Chem.,
November 3, 2000;
275(45):
35424 - 35431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Small, K. M. Brown, S. L. Forbes, and S. B. Liggett
Polymorphic Deletion of Three Intracellular Acidic Residues of the alpha 2B-Adrenergic Receptor Decreases G Protein-coupled Receptor Kinase-mediated Phosphorylation and Desensitization
J. Biol. Chem.,
February 9, 2001;
276(7):
4917 - 4922.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|